BI
Bioasis Technologies Inc.
BIOAF · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $11.3K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.30x
PEG N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 70.18%
Book val. growth N/A
EPS growth N/A
Profitability
0 /100
Weak Op. margin 12,784.50%
Gross margin 3,150.25%
FCF margin 9,636.86%
Quality
0 /100
Poor Asset turnover 0.02x
ROIC 621.16%
ROA 130.64%
Debt
54 /100
Moderate Net debt/EBITDA -0.05x
Current ratio 0.70x
Int. coverage -5.50x
Stability
4 /100
Unstable EPS volatility 324.98%
Beta 1.74x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BIOAF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Deborah Ann Rathjen
Employees
4
Headquarters
New Haven
Evenimente viitoare
02 NOV.
Earnings
Upcoming earnings report